Business Combinations (Tables)

12 Months Ended

Dec. 31, 2016

Pro forma Financial Information Adjusted to Give Effect to the Merger

The pro forma financial information has been adjusted to give effect to the merger as if it had occurred on January 1, 2014.

Pro Forma Financial Information

(Unaudited)

	Year Ended December 31,
	2015		2014
	(in millions)
Net Sales	$	7,517.7	$	7,965.2
Net Earnings	$	330.2	$	320.3

Biomet [Member]

Summary of Aggregate Preliminary Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the closing date of the Biomet merger (in millions):

	Final Values
Cash	$	494.8
Accounts receivable, net		527.9
Inventory		1,224.1
Other current assets		25.4
Property, plant and equipment		775.3
Intangible assets not subject to amortization:
Trademarks and trade names		479.0
In-process research and development (IPR&D)		209.0
Intangible assets subject to amortization:
Technology		2,332.1
Customer relationships		4,961.0
Trademarks and trade names		360.0
Other assets		42.6
Goodwill		7,433.2
Total assets acquired		18,864.4
Current liabilities		584.0
Long-term debt		2,740.0
Deferred taxes		3,497.6
Other long-term liabilities		102.9
Total liabilities assumed		6,924.5
Net assets acquired	$	11,939.9

LDR Holding Corporation [Member]

Summary of Aggregate Preliminary Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary estimates of fair value of the assets acquired and liabilities assumed in the LDR merger (in millions):

	July 13, 2016 (initial)		Adjustments			July 13, 2016 (as adjusted)
Cash	$	92.8	$	–		$	92.8
Accounts receivable, net		31.2		–			31.2
Inventory		86.5		13.1			99.6
Other current assets		5.6		–			5.6
Property, plant and equipment		24.7		–			24.7
Intangible assets not subject to amortization:
In-process research and development (IPR&D)		2.0		–			2.0
Intangible assets subject to amortization:
Technology		431.0		21.0			452.0
Customer relationships		132.0		(14.0	)		118.0
Trademarks and trade names		77.0		(6.0	)		71.0
Other assets		17.4		59.4			76.8
Goodwill		527.1		(44.7	)		482.4
Total assets acquired		1,427.3		28.8			1,456.1
Current liabilities		53.3		22.6			75.9
Long-term debt		0.5		–			0.5
Deferred taxes		259.1		6.4			265.5
Other long-term liabilities		0.5		(0.2	)		0.3
Total liabilities assumed		313.4		28.8			342.2
Net assets acquired	$	1,113.9	$	–		$	1,113.9

Cayenne Medical, CTC [Member]

Summary of Aggregate Preliminary Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the aggregate preliminary estimates of fair value of the assets acquired and liabilities assumed related to the Cayenne Medical, CTC, CD Diagnostics, MedTech, and other immaterial acquisitions that occurred during 2016 (in millions):

Current assets	$	64.2
Property, plant and equipment		3.9
Intangible assets		211.3
Goodwill		340.0
Other assets		7.9
Total assets acquired		627.3
Current liabilities		13.6
Long-term liabilities		110.4
Total liabilities assumed		124.0
Net assets acquired	$	503.3